11/15/2025
Patient Case Story: TB
Short Excerpt: TB first came to Meakin Metabolic Care not as a patient, but as a caregiver. While researching metabolic therapies to support his wife, who was undergoing breast cancer treatment, he discovered that the clinic also offered proactive health programs for people without cancer who want to reduce future health risks. His story illustrates how combining the Prenuvo whole‑body MRI screening with advanced lab analysis and metabolic care can reveal hidden issues and provide a clear, personalized roadmap for both prevention and treatment.
Patient Profile
- Age: 47 years
- Gender: Male
- Diagnosis: Vestibular Schwannoma
Choosing a Preventive Approach
TB enrolled in the Whole Body Prenuvo MRI Scan combined with the MD Predict Lab Panels and MD Review Metabolic Care Program. This program is a proactive health screening pathway designed to identify issues before they become serious.
Why Prenuvo?
Prenuvo’s advanced whole-body MRI uses no radiation and no contrast agents, making it safe for repeated monitoring. The scan evaluates more than 500 possible conditions across 26 regions of the body, including tumors, aneurysms, organ abnormalities, inflammation, nerve conditions, and more.
Patients often choose Prenuvo because:
- It reveals issues before symptoms appear.
- It allows for early, non-invasive detection.
- It supports long-term preventive planning.
- It is completely radiation-free, unlike CT scans or PET scans.
TB’s program also included:
- MD Predict Lab Panels: Extensive lab testing focused on metabolic, inflammatory, hormonal, and organ function markers, designed to reveal early metabolic and cardiovascular risk.
- Metabolic Optimization (MOP) & PhenoAge Calculator: His lab values were entered into a biological age calculator that estimates how well his body is functioning. Compared with his chronological age, this tool can help guide targeted interventions to slow or potentially reverse negative aspects of biological aging.
- MD Review and Care Plan: A 50‑minute virtual consultation with a physician who reviewed his intake survey, MRI findings, and lab results and then worked with TB to define goals, refine lifestyle, and consider medications and supplements when evidence‑based and appropriate.
Test Results
According to the Metabolic Optimization and PhenoAge assessment, TB’s MOP calculator results indicated he was functioning quite well overall, although there were a few areas where improvement could slow long-term aging. His physician recommended:
- Minor lifestyle adjustments
- A few carefully selected supplements
- Low-dose medications to optimize his LDL cholesterol and A1c
- A follow-up in six months
TB’s Prenuvo scan identified two unexpected findings. First, it showed a cyst in his knee, a minor, localized issue that would not have otherwise been apparent and could be monitored conservatively. More importantly, the scan detected an “indeterminate brain tumor highly likely to be benign based on its shape and location.”
Confirming the diagnosis: Vestibular Schwannoma
TB’s next step was to seek expert opinions. He consulted specialists at Dana Farber and an oncology and neurosurgical team at Yale. After targeted brain imaging and review, the lesion was diagnosed as a vestibular schwannoma, also known as an acoustic neuroma.
A vestibular schwannoma is a benign, usually slow‑growing tumor that arises from Schwann cells on the vestibulocochlear nerve (cranial nerve VIII), which carries balance and hearing information from the inner ear to the brain. These tumors account for the vast majority of masses found at the cerebellopontine angle of the brain. They are typically noncancerous, but they can cause significant problems by compressing nearby structures as they enlarge.
In many people, the first signs are one‑sided hearing loss (especially at high frequencies), tinnitus (ringing in the ear), or problems with balance or dizziness. As the tumor grows larger, it can press on the facial nerve and trigeminal nerve, leading to facial weakness, numbness, or pain. In advanced cases, it can compress the brainstem, causing headaches, difficulty walking, or even life threatening complications. TB was not experiencing any of these symptoms.
Most vestibular schwannomas grow slowly, typically 1–1.5 mm per year. If left undetected, they can eventually reach 4–6 cm and may cause sudden neurological symptoms requiring urgent surgery.
A Personalized Path Forward
TB’s medical team reassured him that, given the small size and lack of symptoms, it was safe to monitor the growth closely and immediate intervention wasn’t necessary. However, ongoing MRI surveillance would be essential to ensure the growth wasn’t increasing in size.
Treatment options, when needed, typically include:
• Stereotactic radiosurgery (radiation) to halt growth
• Surgical removal for larger or symptomatic tumors
For now, active monitoring is the best approach.
This plan gives TB the ability to care for his wife with peace of mind, while still managing his own health needs.
The Power of Early Detection
TB firmly believes that the Prenuvo scan changed the trajectory of his health. Without it, the tumor could have continued to grow unnoticed until it caused hearing loss, facial paralysis, or a medical emergency.
Instead, he has:
- A clear diagnosis
- A monitoring plan
- Time to make thoughtful decisions
- Confidence that he’s protecting his long term health
TB’s reflections and key takeaways
The emotional impact of learning that he has a brain tumor was profound. TB started his process seeking reassurance and prevention, not expecting a neurosurgical diagnosis.
TB credits the Prenuvo Whole Body MRI and the integrated Metabolic Care program with identifying his vestibular schwannoma at a stage when he still had choices and time to plan.
TB sees several lessons in his journey:
- Proactive screening can matter, especially for people with a strong family history of cancer or other serious illnesses. While Prenuvo is not a replacement for standard guideline-based screenings, it can be a powerful supplemental tool for early detection.
- Comprehensive, lab-based metabolic assessment and biological age analysis help shift care from a ‘normal versus abnormal’ mindset to ‘optimal versus improvable’. This can help guide targeted interventions in cholesterol, glucose control, and lifestyle before disease develops.
- Early detection of a vestibular schwannoma allows patients to have the widest range of options.
For TB, the most important outcome is that he can continue caring for his family with more confidence, knowing that his own hidden risk has been brought into light and is now under careful, ongoing observation.
References
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7669921/
- https://www.prevention.com/health/a65489698/prenuvo-whole-body-mri-review/
- https://en.wikipedia.org/wiki/Vestibular_schwannoma
- https://www.docancer.org/blog/i-got-a-prenuvo-full-body-scan-heres-my-experience
- https://www.sciencedirect.com/topics/medicine-and-dentistry/vestibular-schwannoma
- https://prenuvo.com
- https://www.nidcd.nih.gov/health/vestibular-schwannoma-acoustic-neuroma-and-neurofibromatosis
- https://my.clevelandclinic.org/health/diseases/16400-acoustic-neuroma
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6954440/
